Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Sualp Tansan"'
Autor:
Mustafa Özdoğan, Eirini Papadopoulou, Nikolaos Tsoulos, Aikaterini Tsantikidi, Vasiliki-Metaxa Mariatou, Georgios Tsaousis, Evgenia Kapeni, Evgenia Bourkoula, Dimitrios Fotiou, Georgios Kapetsis, Ioannis Boukovinas, Nikolaos Touroutoglou, Athanasios Fassas, Achilleas Adamidis, Paraskevas Kosmidis, Dimitrios Trafalis, Eleni Galani, George Lypas, Bülent Orhan, Sualp Tansan, Tahsin Özatlı, Onder Kırca, Okan Çakır, George Nasioulas
Publikováno v:
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-21 (2021)
Abstract Background Tumor molecular profile analysis by Next Generation Sequencing technology is currently widely applied in clinical practice and has enabled the detection of predictive biomarkers of response to targeted treatment. In parallel with
Externí odkaz:
https://doaj.org/article/4d6aebbe3cc044afac237bd8eaa91cee
Autor:
Georgios N. Tsaousis, Eirini Papadopoulou, Angela Apessos, Konstantinos Agiannitopoulos, Georgia Pepe, Stavroula Kampouri, Nikolaos Diamantopoulos, Theofanis Floros, Rodoniki Iosifidou, Ourania Katopodi, Anna Koumarianou, Christos Markopoulos, Konstantinos Papazisis, Vasileios Venizelos, Ioannis Xanthakis, Grigorios Xepapadakis, Eugeniu Banu, Dan Tudor Eniu, Serban Negru, Dana Lucia Stanculeanu, Andrei Ungureanu, Vahit Ozmen, Sualp Tansan, Mehmet Tekinel, Suayib Yalcin, George Nasioulas
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-19 (2019)
Abstract Background Hereditary cancer predisposition syndromes are responsible for approximately 5–10% of all diagnosed cancer cases. In the past, single-gene analysis of specific high risk genes was used for the determination of the genetic cause
Externí odkaz:
https://doaj.org/article/dc43f140d22c4f09805d95f871555460
Publikováno v:
Respiratory Medicine Case Reports, Vol 22, Iss C, Pp 117-122 (2017)
Non-small cell lung cancer (NSCLC) is a frequent tumor entity with high mortality. Although several newly discovered chromosomal translocations and mutations opened new horizons for targeted therapy, literature still lacks large series of NSCLC with
Externí odkaz:
https://doaj.org/article/5a9a7497429641b9ac629cd7023bfb70
Autor:
Nikolaos Tsoulos, Konstantinos Agiannitopoulos, Georgia Pepe, Eirini Papadopoulou, Georgios N Tsaousis, Despina Apostolopoulou, Angeliki Meintani, Vassileios Venizelos, Christos Markopoulos, Rodoniki Iosifidou, Sofia Karageorgopoulou, Christos Christodoulou, Ioannis Natsiopoulos, Konstantinos Papazisis, Maria Vasilaki-Antonatou, Eleftherios Kabletsas, Amanta Psyrri, Stylianos Giassas, Dimitrios Ziogas, Efthalia Lalla, Anna Koumarianou, Christos Papadimitriou, Vahit Ozmen, Sualp Tansan, Kerim Kaban, Tahsin Ozatlı, Dan Tudor Eniu, Angelica Chiorean, Alexandru Blidaru, George Nasioulas
Publikováno v:
Cancer Research. 82:P2-09
Background: Breast cancer is the most frequently diagnosed cancer in women and about 10% of breast cancer cases are hereditary. BRCA1 and BRCA2 are the genes most frequently associated with Hereditary Breast Cancer, although there are numerous other
Autor:
Eirini Papadopoulou, Nikolaos Tsoulos, Vasiliki Metaxa-Mariatou, Aikaterini Tsantikidi, Georgios Kapetsis, Chrysiida Florou-Chatzigiannidou, Sonia Maravelaki, Evgenia Bourkoula, Dimitrios Fotiou, Georgios Tsaousis, Nikolaos Touroutoglou, Dimitrios Trafalis, Ioannis Boukovinas, Ioannis Varthalitis, Zacharenia Saridaki, Charalampos Zoublios, Eleni Galani, George Papatsibas, Christos Papadimitriou, Tania Zlatintsi, Polixenia Iorga, Bülent Orhan, Sualp Tansan, Tahsin Özatlı, George Nasioulas
Publikováno v:
Cancer Research. 82:P5-13
Background: Comprehensive tumor analysis by Next Generation Sequencing (NGS) is imperative for targeted and immunotherapy related biomarkers’ analysis in metastatic breast cancer enabling personalization of cancer treatment in these patients. In pa
Autor:
Nikolaos Tsoulos, Sualp Tansan, Georgios N. Tsaousis, Aikaterini Tsantikidi, Dimitrios Fotiou, Bülent Orhan, Achilleas Adamidis, Eleni Galani, George Lypas, Vasiliki-Metaxa Mariatou, Evgenia Bourkoula, George Nasioulas, Ioannis Boukovinas, Okan Çakır, Dimitrios T. Trafalis, Evgenia Kapeni, Paraskevas Kosmidis, Mustafa Ozdogan, Eirini Papadopoulou, Onder Kirca, Tahsin Özatlı, Athanasios Fassas, Georgios Kapetsis, Nikolaos Touroutoglou
Publikováno v:
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-21 (2021)
BMC Medical Genomics
BMC Medical Genomics
Background Tumor molecular profile analysis by Next Generation Sequencing technology is currently widely applied in clinical practice and has enabled the detection of predictive biomarkers of response to targeted treatment. In parallel with targeted
Autor:
Kerim Kaban, Sonia Maravelaki, Vahit Ozmen, Konstantinos Papazisis, Konstantinos Agiannitopoulos, Maria Vasilaki-Antonatou, Christos Markopoulos, Sofia Karageorgopoulou, Stavroula Kampouri, Vassileios Venizelos, Christos Christodoulou, Rodoniki Iosifidou, Georgios N. Tsaousis, Ioannis Natsiopoulos, Georgia Pepe, Athanassios Fassas, Eirini Papadopoulou, Dan Tudor Eniu, Sualp Tansan, George Nasioulas, Angelica Chiorean
Publikováno v:
Cancer Genomics Proteomics
Background Classification of splicing variants (SVs) in genes associated with hereditary cancer is often challenging. The aim of this study was to investigate the occurrence of SVs in hereditary cancer genes and the clinical utility of RNA analysis.
Autor:
GEORGIOS N. TSAOUSIS, EIRINI PAPADOPOULOU, KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, NIKOLAOS TSOULOS, IOANNIS BOUKOVINAS, THEOFANIS FLOROS, RODONIKI IOSIFIDOU, OURANIA KATOPODI, ANNA KOUMARIANOU, CHRISTOS MARKOPOULOS, KONSTANTINOS PAPAZISIS, VASILEIOS VENIZELOS, ACHILLEAS KAPSIMALIS, GRIGORIOS XEPAPADAKIS, AMANDA PSYRRI, EUGENIU BANU, DAN TUDOR ENIU, ALEXANDRU BLIDARU, DANA LUCIA STANCULEANU, ANDREI UNGUREANU, VAHIT OZMEN, SUALP TANSAN, MEHMET TEKINEL, SUAYIB YALCIN, GEORGE NASIOULAS
Publikováno v:
Cancer Genomics Proteomics
Background/Aim: The use of multi-gene panels for germline testing in breast cancer enables the estimation of cancer risk and guides risk-reducing management options. The aim of this study was to present data that demonstrate the different levels of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17928cee2350acf8044f319ac3d2bec4
https://europepmc.org/articles/PMC8717958/
https://europepmc.org/articles/PMC8717958/
Autor:
Ourania Katopodi, George Nasioulas, Stavroula Kampouri, Georgia Pepe, Rodoniki Iosifidou, Dan Tudor Eniu, Eirini Papadopoulou, Anna Koumarianou, Christos Markopoulos, Mehmet Tekinel, Serban Negru, Ioannis Xanthakis, V. Venizelos, Grigorios Xepapadakis, Sualp Tansan, Vahit Ozmen, Konstantinos Papazisis, Suayib Yalcin, Georgios N. Tsaousis, Nikolaos Diamantopoulos, E Banu, Theofanis Floros, Dana Lucia Stanculeanu, Konstantinos Agiannitopoulos, A Ungureanu, Angela Apessos
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-19 (2019)
BMC Cancer
BMC Cancer
Background Hereditary cancer predisposition syndromes are responsible for approximately 5–10% of all diagnosed cancer cases. In the past, single-gene analysis of specific high risk genes was used for the determination of the genetic cause of cancer
Publikováno v:
Journal of Clinical Oncology. 40:e17550-e17550
e17550 Background: Ovarian cancer (OC) is the the leading cause of cancer death in females. Most cases present at advanced stage. Standard treatment is cytoreductive surgery before or after paclitaxel and carboplatin chemotherapy (CT) followed by mai